The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(24)00208-X/abstract?utm_campaign=update-lanres&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanres&_hsenc=p2ANqtz-8GTmFTHOAXpLIuGL7CeLhi4g9JElfpP4GpQz8siyFAJqGP4HbNs3g3OnTGNjuSub_2Bx0YAox32iBLJcQwJgxh08l5yg&_hsmi=333370133&utm_content=333357343&utm_source=hs_email